chr8-11808709-GTCCCAC-G

Position:

• chr8-11808709-GTCCCAC-G

Variant summary

Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP6 BA1

The NM_004462.5(FDFT1):​c.100-51_100-46del variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.933 in 1,514,496 control chromosomes in the GnomAD database, including 660,457 homozygotes. Variant has been reported in ClinVar as Benign (no stars).

• Frequency:
  • Genomes: 𝑓 0.89 (58797 hom., cov: 0)
  • Exomes 𝑓: 0.94 (601660 hom.)
• Consequence: FDFT1 NM_004462.5 intron
• Clinical Significance: Benign no assertion criteria provided B:1
• Conservation: PhyloP100: 1.40

Genes affected

FDFT1 (HGNC:3629): (farnesyl-diphosphate farnesyltransferase 1) This gene encodes a membrane-associated enzyme located at a branch point in the mevalonate pathway. The encoded protein is the first specific enzyme in cholesterol biosynthesis, catalyzing the dimerization of two molecules of farnesyl diphosphate in a two-step reaction to form squalene. [provided by RefSeq, Jul 2008]

ACMG classification

Verdict is Benign. Variant got -9 ACMG points.

• BP6: Variant 8-11808709-GTCCCAC-G is Benign according to our data. Variant chr8-11808709-GTCCCAC-G is described in ClinVar as [Benign]. Clinvar id is 3060113.Status of the report is no_assertion_criteria_provided, 0 stars. Variant chr8-11808709-GTCCCAC-G is described in Lovd as [Benign].
• BA1: GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.942 is higher than 0.05.

Transcripts

RefSeq

Gene	Transcript	HGVSc	HGVSp	Effect	#exon/exons	MANE	UniProt
FDFT1	NM_004462.5	c.100-51_100-46del		intron_variant		ENST00000220584.9

Ensembl

Gene	Transcript	HGVSc	HGVSp	Effect	#exon/exons	TSL	MANE	Appris	UniProt
FDFT1	ENST00000220584.9	c.100-51_100-46del		intron_variant		1	NM_004462.5	P1

Frequencies

GnomAD3 genomes AF: 0.887 AC: 131994 AN: 148834 Hom.: 58785 Cov.: 0

Gnomad AFR AF: 0.763

Gnomad AMI AF: 0.975

Gnomad AMR AF: 0.886

Gnomad ASJ AF: 0.926

Gnomad EAS AF: 0.966

Gnomad SAS AF: 0.948

Gnomad FIN AF: 0.900

Gnomad MID AF: 0.926

Gnomad NFE AF: 0.944

Gnomad OTH AF: 0.898

GnomAD4 exome AF: 0.938 AC: 1280896 AN: 1365550 Hom.: 601660 AF XY: 0.939 AC XY: 631346 AN XY: 672392

Gnomad4 AFR exome AF: 0.741

Gnomad4 AMR exome AF: 0.856

Gnomad4 ASJ exome AF: 0.929

Gnomad4 EAS exome AF: 0.961

Gnomad4 SAS exome AF: 0.947

Gnomad4 FIN exome AF: 0.912

Gnomad4 NFE exome AF: 0.947

Gnomad4 OTH exome AF: 0.927

GnomAD4 genome AF: 0.887 AC: 132045 AN: 148946 Hom.: 58797 Cov.: 0 AF XY: 0.885 AC XY: 64258 AN XY: 72586

Gnomad4 AFR AF: 0.762

Gnomad4 AMR AF: 0.886

Gnomad4 ASJ AF: 0.926

Gnomad4 EAS AF: 0.965

Gnomad4 SAS AF: 0.948

Gnomad4 FIN AF: 0.900

Gnomad4 NFE AF: 0.944

Gnomad4 OTH AF: 0.899

ClinVar

Significance: Benign

Submissions summary: Benign:1

Revision: no assertion criteria provided

Submissions by phenotype

FDFT1-related disorder Benign:1

Benign, no assertion criteria provided

clinical testing

PreventionGenetics, part of Exact Sciences

Sep 05, 2019

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Other links and lift over

dbSNP: rs71711801; hg19: chr8-11666218;